Oncology
ONCOLOGY Vol 25 No 13
Volume: 25
Issue: 13
ONCOLOGY Vol 25 No 12_Suppl_2
Volume: 25
Issue: 12_Suppl_2
ONCOLOGY Vol 25 No 12
Volume: 25
Issue: 12
ONCOLOGY Vol 25 No 11
Volume: 25
Issue: 11
ONCOLOGY Vol 25 No 10
Volume: 25
Issue: 10
ONCOLOGY Vol 25 No 9
Volume: 25
Issue: 9
ONCOLOGY Vol 25 No 5
Volume: 25
Issue: 5
ONCOLOGY Vol 25 No 4
Volume: 25
Issue: 4
ONCOLOGY Vol 25 No 3
Volume: 25
Issue: 3
ONCOLOGY Vol 25 No 6
Volume: 25
Issue: 6
ONCOLOGY Vol 25 No 2
Volume: 25
Issue: 2
ONCOLOGY Vol 25 No 1
Volume: 25
Issue: 1
ONCOLOGY Vol 24 No 12_Suppl_5
Volume: 24
Issue: 12_Suppl_5
ONCOLOGY Vol 24 No 12
Volume: 24
Issue: 12
ONCOLOGY Vol 24 No 13
Volume: 24
Issue: 13
ONCOLOGY Vol 24 No 11
Volume: 24
Issue: 11
ONCOLOGY Vol 24 No 10
Volume: 24
Issue: 10
ONCOLOGY Vol 24 No 9
Volume: 24
Issue: 9
ONCOLOGY Vol 24 No 8
Volume: 24
Issue: 8
ONCOLOGY Vol 24 No 7
Volume: 24
Issue: 7
ONCOLOGY Vol 24 No 6
Volume: 24
Issue: 6
ONCOLOGY Vol 24 No 5
Volume: 24
Issue: 5
ONCOLOGY Vol 24 No 4
Volume: 24
Issue: 4
ONCOLOGY Vol 24 No 3_Suppl_2
Volume: 24
Issue: 3_Suppl_2
ONCOLOGY Vol 24 No 3
Volume: 24
Issue: 3
ONCOLOGY Vol 24 No 2
Volume: 24
Issue: 2
ONCOLOGY Vol 24 No 1_Suppl_1
Volume: 24
Issue: 1_Suppl_1
ONCOLOGY Vol 24 No 14
Volume: 24
Issue: 14
ONCOLOGY Vol 24 No 1
Volume: 24
Issue: 1
ONCOLOGY Vol 23 No 14_Suppl_5
Volume: 23
Issue: 14_Suppl_5
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
3
FDA Approves Revumenib in R/R NPM1-Mutant AML
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
